Sarah Knowles1, Jessica Maxwell1, Alycya Lumsden1, Lydia Pearson1, Jessica Pulhin1, Jesse McLean1, Muriel Brackstone1, Renee Hanrahan1. 1. From Western University, London, Ont. (Knowles, Brackstone); the University of Nebraska Medical Center, Omaha, Neb. (Maxwell); Georgian College, Barrie, Ont. (Lumsden, Pearson, Pulhin); Royal Victoria Regional Health Centre, Barrie, Ont. (McLean, Hanrahan); and McMaster University, Hamilton, Ont. (Hanrahan).
Abstract
Background: Oncoplastic surgery (OPS) is becoming the new standard of care for breast-conserving surgery (BCS). It has become increasingly popular in Europe; however, it has not yet been widely accepted in North America. This study aims to describe the experience with OPS at a Canadian tertiary care centre. Methods: This study is a retrospective case series consisting of consecutive OPS cases at a single Canadian centre, the Royal Victoria Regional Health Centre in Barrie, Ontario, between 2009 and 2015. Results: A total of 275 women who consecutively underwent OPS were included. The average size of the tumour was 17 mm (standard deviation [SD] 13 mm; range 0–110 mm). The average specimen weight was 155 g (SD 146 g; range 15–1132 g). Invasive ductal carcinoma was the most common diagnosis (237 patients, 86.2%), followed by ductal carcinoma in situ (18 patients, 6.6%) and then invasive lobular carcinoma (15 patients, 5.5%). A positive margin was recorded in 37 (13.5%) patients. Immediate postoperative complications included seroma and edema (32.7%), wound infection (13.1%), hematoma (8.7%) and delayed wound healing (6.5%). A delay to adjuvant therapy due to postoperative complications occurred in 7 of 217 (3.2%) patients. The median follow-up was 18 months. There were local and distant recurrences in 9 (3.3%) and 2 (0.7%) patients, respectively. Overall survival was 99.3%. Conclusion: The findings of this study are comparable to results in the literature on OPS and demonstrate that OPS is an attractive alternative to standard lumpectomy for Canadian general surgeons who treat breast cancer.
Background: Oncoplastic surgery (OPS) is becoming the new standard of care for breast-conserving surgery (BCS). It has become increasingly popular in Europe; however, it has not yet been widely accepted in North America. This study aims to describe the experience with OPS at a Canadian tertiary care centre. Methods: This study is a retrospective case series consisting of consecutive OPS cases at a single Canadian centre, the Royal Victoria Regional Health Centre in Barrie, Ontario, between 2009 and 2015. Results: A total of 275 women who consecutively underwent OPS were included. The average size of the tumour was 17 mm (standard deviation [SD] 13 mm; range 0–110 mm). The average specimen weight was 155 g (SD 146 g; range 15–1132 g). Invasive ductal carcinoma was the most common diagnosis (237 patients, 86.2%), followed by ductal carcinoma in situ (18 patients, 6.6%) and then invasive lobular carcinoma (15 patients, 5.5%). A positive margin was recorded in 37 (13.5%) patients. Immediate postoperative complications included seroma and edema (32.7%), wound infection (13.1%), hematoma (8.7%) and delayed wound healing (6.5%). A delay to adjuvant therapy due to postoperative complications occurred in 7 of 217 (3.2%) patients. The median follow-up was 18 months. There were local and distant recurrences in 9 (3.3%) and 2 (0.7%) patients, respectively. Overall survival was 99.3%. Conclusion: The findings of this study are comparable to results in the literature on OPS and demonstrate that OPS is an attractive alternative to standard lumpectomy for Canadian general surgeons who treat breast cancer.
Authors: Lucy De La Cruz; Stephanie A Blankenship; Abhishek Chatterjee; Rula Geha; Nadia Nocera; Brian J Czerniecki; Julia Tchou; Carla S Fisher Journal: Ann Surg Oncol Date: 2016-06-29 Impact factor: 5.344
Authors: Krishna B Clough; Raquel F D van la Parra; Helene H Thygesen; Eric Levy; Elisabeth Russ; Najeeb M Halabi; Isabelle Sarfati; Claude Nos Journal: Ann Surg Date: 2018-07 Impact factor: 12.969
Authors: Meena S Moran; Stuart J Schnitt; Armando E Giuliano; Jay R Harris; Seema A Khan; Janet Horton; Suzanne Klimberg; Mariana Chavez-MacGregor; Gary Freedman; Nehmat Houssami; Peggy L Johnson; Monica Morrow Journal: Int J Radiat Oncol Biol Phys Date: 2014-03-01 Impact factor: 7.038
Authors: L Calì Cassi; G Vanni; G Petrella; P Orsaria; C Pistolese; G Lo Russo; M Innocenti; O Buonomo Journal: Eur Rev Med Pharmacol Sci Date: 2016-07 Impact factor: 3.507
Authors: Abhishek Chatterjee; Jennifer Gass; M Barbara Burke; Katherine Kopkash; Mahmoud B El-Tamer; Dennis R Holmes; Patricia Clark; Juliann Reiland Journal: Ann Surg Oncol Date: 2018-07-12 Impact factor: 5.344
Authors: Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark Journal: N Engl J Med Date: 2002-10-17 Impact factor: 91.245